New shot aims to boost platelets in chronic blood disorder

NCT ID NCT05070845

Recruiting now Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Feb 26, 2026 · Last updated May 05, 2026 · Updated 5 times

Summary

This study tests an experimental drug called PF-06835375 in adults with moderate to severe primary immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. The drug is given as multiple injections under the skin. The main goal is to see if it safely raises platelet counts. About 91 participants with persistent or chronic ITP will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AIDPORT Sp. z o.o.
RECRUITING

Skórzewo, Greater Poland Voivodeship, 60-185, Poland
Addenbrooke's Hospital
RECRUITING

Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom
Calvary Mater Newcastle
RECRUITING

Waratah, New South Wales, 2298, Australia
Derriford Hospital
RECRUITING

Plymouth, Devon, Pl6 8DH, United Kingdom
East Carolina University
RECRUITING

Greenville, North Carolina, 27834, United States
Fakultni nemocnice Hradec Kralove
RECRUITING

Hradec Králové, 500 05, Czechia
Fakultni nemocnice Kralovske Vinohrady
NOT_YET_RECRUITING

Prague, 100 34, Czechia
Fakultni nemocnice Ostrava
RECRUITING

Ostrava - Poruba, 708 52, Czechia
Flinders Medical Centre
RECRUITING

Bedford Park, South Australia, 5042, Australia
Hammersmith Hospital
RECRUITING

London, W12 0HS, United Kingdom
ICON Cancer Centre - Kurralta Park
RECRUITING

Kurralta Park, South Australia, 5037, Australia
InterHem
ACTIVE_NOT_RECRUITING

Bialystok, 15-732, Poland
Klinika Hematologii i Transplantologii Uniwersyteckie Centrum Kliniczne
ACTIVE_NOT_RECRUITING

Gdansk, 80-214, Poland
Komárom-Esztergom Vármegyei Szent Borbála Kórház
NOT_YET_RECRUITING

Tatabánya, H-2800, Hungary
Liverpool Hospital
RECRUITING

Liverpool, New South Wales, 2170, Australia
McGill University Health Centre
RECRUITING

Montreal, Quebec, H4A 3J1, Canada
Petz Aladár Egyetemi Oktató Kórház
RECRUITING

Győr, 9024, Hungary
Pratia Onkologia Katowice
RECRUITING

Katowice, 40-519, Poland
Pécsi Tudományegyetem Klinikai Központ
ACTIVE_NOT_RECRUITING

Pécs, Baranya, 7624, Hungary
Royal Perth Hospital
RECRUITING

Perth, Western Australia, 6000, Australia
Semmelweis University
RECRUITING

Budapest, 1088, Hungary
Slade Pharmacy
RECRUITING

Mount Kuring-Gai, New South Wales, 2080, Australia
Somogy Megyei Kaposi Mór Oktató Kórház
RECRUITING

Kaposvár, Somogy County, 7400, Hungary
South West Radiology
RECRUITING

Liverpool, New South Wales, 2170, Australia
The Alfred Hospital
RECRUITING

Melbourne, Victoria, 3004, Australia
The Royal Cornwall Hospital
RECRUITING

Truro, England, TR1 3LJ, United Kingdom
Tolna Varmegyei Balassa Janos Korhaz
NOT_YET_RECRUITING

Szekszárd, 7100, Hungary
Unity Health Toronto, St. Michael's Hospital
RECRUITING

Toronto, Ontario, M5B 1W8, Canada
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
RECRUITING

Wroclaw, 50-367, Poland
Uniwersytecki Szpital Kliniczny w Poznaniu
ACTIVE_NOT_RECRUITING

Poznan, 60-569, Poland
Vseobecna fakultni nemocnice v Praze
RECRUITING

Prague, 12808, Czechia

Conditions

Explore the condition pages connected to this study.

PRIMARY IMMUNE THROMBOCYTOPENIA